These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 3778754)

  • 1. Treatment of chronic inflammatory demyelinating polyradiculoneuropathy by plasma filtration.
    Abe Y; Baba M; Baba T; Tamasawa N; Kurahashi K; Hirai Y; Nakahata H; Matsunaga M; Takebe K
    ASAIO Trans; 1986; 32(1):486-9. PubMed ID: 3778754
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-term treatment of chronic relapsing inflammatory demyelinating polyradiculoneuropathy: combination of corticosteroids, plasma exchange, and intravenous immunoglobulins.
    Briellmann RS; Nydegger UE; Sturzenegger M; Fierz L; Hess CW; Hauser SP
    Eur Neurol; 1998; 39(3):190-1. PubMed ID: 9605400
    [No Abstract]   [Full Text] [Related]  

  • 3. Recurrent aseptic meningitis complicating intravenous immunoglobulin therapy for chronic inflammatory demyelinating polyradiculoneuropathy.
    Vera-Ramirez M; Charlet M; Parry GJ
    Neurology; 1992 Aug; 42(8):1636-7. PubMed ID: 1641167
    [No Abstract]   [Full Text] [Related]  

  • 4. Anti-D immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy.
    Vermeulen M; van Schaik IN; Brand A
    J Neurol Neurosurg Psychiatry; 1995 Mar; 58(3):383-4. PubMed ID: 7897433
    [No Abstract]   [Full Text] [Related]  

  • 5. [Plasmapheresis in chronic inflammatory demyelinating polyradiculoneuropathy].
    Tanaka M
    Rinsho Shinkeigaku; 1998 Sep; 38(9):853; author reply 854. PubMed ID: 10078041
    [No Abstract]   [Full Text] [Related]  

  • 6. Plasma exchange in chronic inflammatory demyelinating polyradiculoneuropathy.
    Dyck PJ; Daube J; O'Brien P; Pineda A; Low PA; Windebank AJ; Swanson C
    N Engl J Med; 1986 Feb; 314(8):461-5. PubMed ID: 3511382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma exchange in chronic inflammatory demyelinating polyradiculoneuropathy; different beneficial effects and their correlation to the clinical features.
    Kumazawa K; Sobue G; Yamamoto K; Kitano M; Nakamura S; Kato K; Mitsuma T
    Intern Med; 1995 Jun; 34(6):537-41. PubMed ID: 7549138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of high-dose intravenous immunoglobulins in demyelinating diseases.
    Stangel M; Toyka KV; Gold R
    Arch Neurol; 1999 Jun; 56(6):661-3. PubMed ID: 10369303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic demyelinating polyneuropathy in pregnancy treated with intravenous immunoglobulin.
    Nwosu EC; Tandon S; Breeze C; Enevoldson TP; Khaleeli AA
    Br J Obstet Gynaecol; 1999 Feb; 106(2):174-6. PubMed ID: 10426685
    [No Abstract]   [Full Text] [Related]  

  • 10. The mechanism of action of intravenous immunoglobulin in patients with chronic inflammatory demyelinating polyneuropathy.
    Brand A; Van Doorn PA; Rossi F; Kazatchkine MD; Vermeulen M
    Prog Clin Biol Res; 1990; 337():405-9. PubMed ID: 2353004
    [No Abstract]   [Full Text] [Related]  

  • 11. [Chronic inflammatory demyelinating polyneuropathy (CIDP)].
    Tanaka H; Baba M
    Ryoikibetsu Shokogun Shirizu; 1999; (27 Pt 2):479-82. PubMed ID: 10434704
    [No Abstract]   [Full Text] [Related]  

  • 12. A novel trial design to study the effect of intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy.
    Thompson N; Choudhary P; Hughes RA; Quinlivan RM
    J Neurol; 1996 Mar; 243(3):280-5. PubMed ID: 8936360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Steroid therapy and plasmapheresis in chronic inflammatory demyelinating polyradiculoneuropathy: a long-term follow-up study].
    Hanaoka N; Hanyu N; Yanagisawa N
    Rinsho Shinkeigaku; 1998 Mar; 38(3):208-12. PubMed ID: 9711115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic inflammatory demyelinating polyradiculoneuropathy.
    Mendell JR
    Annu Rev Med; 1993; 44():211-9. PubMed ID: 8476243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chronic inflammatory demyelinating polyradiculoneuropathy].
    Jakobsen JK; Lauritzen MJ; Krarup C
    Ugeskr Laeger; 1991 Sep; 153(36):2474-7. PubMed ID: 1926597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chronic inflammatory demyelinating polyradiculoneuropathy of acute onset: relapse after temporary improvement by plasma exchange and longstanding remission by corticosteroid therapy].
    Iwatsubo T; Sakanaka C; Obi T; Takeda K; Sakuta M
    Rinsho Shinkeigaku; 1989 Jul; 29(7):930-2. PubMed ID: 2805518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A plasma exchange versus immune globulin infusion trial in chronic inflammatory demyelinating polyradiculoneuropathy.
    Dyck PJ; Litchy WJ; Kratz KM; Suarez GA; Low PA; Pineda AA; Windebank AJ; Karnes JL; O'Brien PC
    Ann Neurol; 1994 Dec; 36(6):838-45. PubMed ID: 7998769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement of neurologic function in chronic inflammatory demyelinating polyradiculoneuropathy following intravenous gamma-globulin infusion.
    Albala M; McNamara ME; Sokol M; Wyshock E
    Arch Neurol; 1987 Mar; 44(3):248-9. PubMed ID: 2435270
    [No Abstract]   [Full Text] [Related]  

  • 19. Intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy and in neuropathy associated with IgM monoclonal gammopathy of unknown significance.
    Dyck PJ
    Neurology; 1990 Feb; 40(2):327-8. PubMed ID: 2300259
    [No Abstract]   [Full Text] [Related]  

  • 20. Modulating the immune response in demyelinating diseases.
    Hughes R
    J Neurol Neurosurg Psychiatry; 1998 Feb; 64(2):148. PubMed ID: 9489519
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.